ProjectNeoVitaA – A prospective, multicenter, double blind, placebo-controlled, two-arm parallel group phase 3 trialto…
Basic data
Acronym:
NeoVitaA
Title:
A prospective, multicenter, double blind, placebo-controlled, two-arm parallel group phase 3 trialto evaluate the effect of early postnatal additional high dose oral vitamin A supplementation of5000 IU/kg/d versus placebo for 28 days for preventing bronchopulmonary dysplasia (BPD) ordeath in extremely low birth weight (ELBW) infants.
Duration:
20/04/2016 to 20/04/2018
Abstract / short description:
The aim of this trial is to assess the role of early postnatal additional high-dose oral Vitamin A supplementation versus placebo for 28 days for preventing BPD or death in ELBW infants.
Keywords:
pediatrics
Pädiatrie
Involved staff
Managers
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Paediatrics Department IV
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Saarbrücken, Saarland, Germany